Yang Lu

10PUBLICATIONS
112CO-AUTHORS
Cancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersTumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 17, 2026
Metabolic Tumor Volume Is More Accurate Than SUV Metrics in PSMA-PET/CT Analysis Across Different PET/CT Scanners.

|Mar 04, 2026
131I-LNTH-1095 Radioligand Therapy plus Enzalutamide versus Enzalutamide Alone in Men with PSMA-Avid Metastatic Castration-Resistant Prostate Cancer: A Phase II Study.

Evan Y Yu, Vivek Narayan, Giuseppe Esposito

|Apr 11, 2024
Enhancing NSCLC recurrence prediction with PET/CT habitat imaging, ctDNA, and integrative radiogenomics-blood insights.

Sheeba J Sujit, Muhammad Aminu, Tatiana V Karpinets

|May 29, 2023
Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance.

Yanshuo Chu, Enyu Dai, Yating Li

|Aug 11, 2022
Smart Start: Rituximab, Lenalidomide, and Ibrutinib in Patients With Newly Diagnosed Large B-Cell Lymphoma.

Jason Westin, R Eric Davis, Lei Feng

|Apr 05, 2022
MTAP deficiency creates an exploitable target for antifolate therapy in 9p21-loss cancers.

Omar Alhalabi, Jianfeng Chen, Yuxue Zhang

Pageof 2

Frequent Collaborators

5 joint publications

Linghua Wang

4 joint publications

Jaffer Ajani

4 joint publications

Guangchun Han

3 joint publications

Andrew Futreal